Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is defined by the degeneration of nigral dopaminergic (DA) neurons and can be caused by monogenic mutations of genes such as parkin. The lack of phenotype in parkin knockout mice suggests that human nigral DA neurons have unique vulnerabilities. Here we generate induced pluripotent stem cells from normal subjects and PD patients with parkin mutations. We demonstrate that loss of parkin in human midbrain DA neurons greatly increases the transcription of monoamine oxidases and oxidative stress, significantly reduces DA uptake and increases spontaneous DA release. Lentiviral expression of parkin, but not its PD-linked mutant, rescues these phenotypes. The results suggest that parkin controls dopamine utilization in human midbrain DA neurons by enhancing the precision of DA neurotransmission and suppressing dopamine oxidation. Thus, the study provides novel targets and a physiologically relevant screening platform for disease-modifying therapies of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PD patient iPSC-derived dopaminergic neurons harboring Parkin mutation displayed decreased microtubule stability, increased oxidative stress, reduced dopamine uptake, and increased spontaneous dopamine release [36,37].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“In sharp contrast to the situation seen in PD patients with parkin mutation”
ResultParkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026 · cited 1×
“Parkin mutations did not significantly affect mitochondria We examined whether the loss of parkin significantly affect mitochondria by treating the four lines of iPSC-derived neurons without or with CCCP (10 μM for 16 h) to induce mitophag”
BackgroundHighly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
MONOAMINE OXIDASE: From Genes to Behavior
Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,206 · cited 1×
“, which are mitochondrial enzymes responsible for the oxidative deamination of dopamine , a reaction that produces large quantities of reactive oxygen specie”
BackgroundHu, B.-Y., Weick, J. P., Yu, J., Ma, L.-X., Zhang, X.-Q., Thomson, J. A., & Zhang, S.-C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910012107 · Cited by 1,013
Oxidative stress and the pathogenesis of Parkinson's disease
Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
Olanow, C. W., Rascol, O., Hauser, R., Feigin, P. D., Jankovic, J., Lang, A., Langston, W., Melamed, E., Poewe, W., Stocchi, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809335 · Cited by 901
Genetic Animal Models of Parkinson's Disease
Dawson, T. M., Ko, H. S., & Dawson, V. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.034 · Cited by 823 · cited 1×
“Discussion One of the critical challenges for PD research is the lack of live human nigral DA neurons for mechanistic studies and drug discovery, as animal models of PD generally do not recapitulate the human condition very wel”
BackgroundNuytemans, K., Theuns, J., Cruts, M., & Van Broeckhoven, C. (2010) · Human Mutation · doi:10.1002/humu.21277 · Cited by 563
A High-Efficiency System for the Generation and Study of Human Induced Pluripotent Stem Cells
Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C., & Hochedlinger, K. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.08.003 · Cited by 563 · cited 1×
“Dermal fibroblasts cultured from skin punch biopsy were reprogrammed to iPSCs using lentiviruses expressing human Oct4, Sox2, Klf4, c-Myc and Nano”
MethodA functionally characterized test set of human induced pluripotent stem cells
Boulting, G. L., Kiskinis, E., Croft, G. F., Amoroso, M. W., Oakley, D. H., Wainger, B. J., Williams, D. J., Kahler, D. J., Yamaki, M., Davidow, L., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1783 · Cited by 489
Directed Differentiation of Dopaminergic Neuronal Subtypes from Human Embryonic Stem Cells
Yan, Y., Yang, D., Zarnowska, E. D., Du, Z., Werbel, B., Valliere, C., Pearce, R. A., Thomson, J. A., & Zhang, S. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0365 · Cited by 488 · cited 1×
“Differentiation of iPSCs to midbrain DA neurons We used a feeder-free, chemically defined, directed differentiation protoco”
MethodGiros, B., el Mestikawy, S., Godinot, N., Zheng, K., Han, H., Yang-Feng, T., & Caron, M. G. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08925-4 · Cited by 477
Parkin-deficient mice are not a robust model of parkinsonism
Perez, F. A., & Palmiter, R. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409598102 · Cited by 477
The role of parkin in familial and sporadic Parkinson's disease
Dawson, T. M., & Dawson, V. L. (2010) · Movement Disorders · doi:10.1002/mds.22798 · Cited by 392
Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory
Yuen, E. Y., Liu, W., Karatsoreos, I. N., Ren, Y., Feng, J., McEwen, B. S., & Yan, Z. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.50 · Cited by 324
Fallon, L., Bélanger, C. M. L., Corera, A. T., Kontogiannea, M., Regan-Klapisz, E., Moreau, F., Voortman, J., Haber, M., Rouleau, G., Thorarinsdottir, T., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1441 · Cited by 317
Engrailed-1 as a target of the Wnt-1 signalling pathway in vertebrate midbrain development
Danielian, P. S., & McMahon, A. P. (1996) · Nature · doi:10.1038/383332a0 · Cited by 290
Oligomerization and Trafficking of the Human Dopamine Transporter
Torres, G. E., Carneiro, A., Seamans, K., Fiorentini, C., Sweeney, A., Yao, W.-D., & Caron, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m201926200 · Cited by 278 · cited 1×
“, a prerequisite for the plasma membrane delivery of this misfolding-prone protei”
BackgroundGenetic Analysis of Pathways to Parkinson Disease
Hardy, J. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.014 · Cited by 274 · cited 1×
“A variety of environmental and genetic factors underlie the accelerated degeneration of nigral DA neurons in P”
BackgroundParkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis
Jiang, H., Ren, Y., Zhao, J., & Feng, J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh180 · Cited by 239 · cited 1×
“Measurement of protein carbonyls The levels of protein carbonyls were measured as described befor”
MethodRhee, Y.-H., Ko, J.-Y., Chang, M.-Y., Yi, S.-H., Kim, D., Kim, C.-H., Shim, J.-W., Jo, A.-Y., Kim, B.-W., Lee, H., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45794 · Cited by 236
da Costa, C. A., Sunyach, C., Giaime, E., West, A., Corti, O., Brice, A., Safe, S., Abou-Sleiman, P. M., Wood, N. W., Takahashi, H., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1981 · Cited by 212 · cited 1×
“Alternatively, the ability of parkin to repress p5”
BackgroundWilly, P. J., Murray, I. R., Qian, J., Busch, B. B., Stevens, W. C., Martin, R., Mohan, R., Zhou, S., Ordentlich, P., Wei, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401420101 · Cited by 196
Homeostatic mechanisms in dopamine synthesis and release: a mathematical model
Best, J. A., Nijhout, H. F., & Reed, M. C. (2009) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-6-21 · Cited by 132
Chen, B. T., & Rice, M. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07841.2001 · Cited by 129
Parkin Increases Dopamine Uptake by Enhancing the Cell Surface Expression of Dopamine Transporter
Jiang, H., Jiang, Q., & Feng, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409282200 · Cited by 122
Mobilization of Calcium from Intracellular Stores Facilitates Somatodendritic Dopamine Release
Patel, J. C., Witkovsky, P., Avshalumov, M. V., & Rice, M. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0181-09.2009 · Cited by 107 · cited 1×
“It suggests that parkin limits somatodendritic DA release, which can be independent of extracellular [Ca 2+”
BackgroundDifferentiation of Neural Precursors and Dopaminergic Neurons from Human Embryonic Stem Cells
Zhang, X.-Q., & Zhang, S.-C. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60761-369-5_19 · Cited by 97
Takenaga, M., Fukumoto, M., & Hori, Y. (2007) · Journal of Cell Science · doi:10.1242/jcs.004127 · Cited by 97
Parkin Suppresses the Expression of Monoamine Oxidases
Jiang, H., Jiang, Q., Liu, W., & Feng, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510926200 · Cited by 88 · cited 1×
“Parkin mutations increased spontaneous DA release To demonstrate that these midbrain DA neurons are functional, we measured spontaneous and activity-dependent dopamine release by reverse phase high pressure liquid chromatography (HPLC) coupled with electrochemical detection of dopamine”
BackgroundParkin degrades estrogen-related receptors to limit the expression of monoamine oxidases
Ren, Y., Jiang, H., Ma, D., Nakaso, K., & Feng, J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq550 · Cited by 74
The Dopamine Transporter Carboxyl-terminal Tail
Lee, F. J. S., Pristupa, Z. B., Ciliax, B. J., Levey, A. I., & Niznik, H. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20885 · Cited by 62 · cited 1×
“and was consistent with other studies using cloned human DAT in exogenous expression system”
ResultRibeiro, M. J., Thobois, S., Lohmann, E., du Montcel, S. T., Lesage, S., Pélissolo, A., Dubois, B., Mallet, L., Pollak, P., Agid, Y., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.063529 · Cited by 43 · cited 1×
“Recent positron emission tomography studies have shown that 18 F-DOPA uptake is significantly reduced in PD patients with parkin mutations, compared with control”
BackgroundIn vivo assessment of brain monoamine systems in parkin gene carriers: A PET study
Pavese, N., Moore, R. Y., Scherfler, C., Khan, N. L., Hotton, G. R., Quinn, N. P., Bhatia, K. P., Wood, N. W., Brooks, D. J., Lees, A. J., et al. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.021 · Cited by 29 · cited 1×
“Recent positron emission tomography studies have shown that 18 F-DOPA uptake is significantly reduced in PD patients with parkin mutations, compared with control”
Background
Research works printed but not linked: 1
- Chambers SM Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Nat Biotechnol 27 275 280 2009 19252484 PMC2756723
Cited by
Induced pluripotent stem cell technology: a decade of progress.
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525
Imaizumi, Y., Okada, Y., Akamatsu, W., Koike, M., Kuzumaki, N., Hayakawa, H., Nihira, T., Kobayashi, T., Ohyama, M., Sato, S., et al. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-35 · Cited by 380
“Because increased levels of oxidative stress have been documented in other PD models [7,10,16,17], we examined oxidative metabolism in the iPSC clones by measuring the cellular levels of reduced glutathione (GSH).”
BackgroundInfluentialMonzio Compagnoni, G., Di Fonzo, A., Corti, S., Comi, G. P., Bresolin, N., & Masliah, E. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01926-1 · Cited by 378
Mitochondrial Regulation in Pluripotent Stem Cells
Xu, X., Duan, S., Yi, F., Ocampo, A., Liu, G.-H., & Izpisua Belmonte, J. C. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.005 · Cited by 374
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
Metadata
- Authors
- Jiang, H., Ren, Y., Yuen, E. Y., Zhong, P., Ghaedi, M., Hu, Z., Azabdaftari, G., Nakaso, K., Yan, Z., & Feng, J.
- Affiliations
- University at Buffalo, State University of New York (US)
- Roswell Park Comprehensive Cancer Center (US)
- Tottori University (JP)
- Corresponding author
- Feng, Jian
- Venue
- Nature Communications
- Published
- 2012-02-07
- Volume
- 3
- Issue
- 1
- Pages
- 668-668
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3498452
- OpenAlex
- W2010478595
- Cited by
- 254
- References
- 39
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 12 · 2023: 10 · 2022: 19 · 2021: 20 · 2020: 16 · 2019: 26 · 2018: 24 · 2017: 16 · 2016: 24 · 2015: 17 · 2014: 18 · 2013: 24 · 2012: 15
- FWCI
- 15.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- Roswell Park Cancer Institute
- State University of New York
- New York State Stem Cell Science
- National Natural Science Foundation of China (30928006)
- National Institutes of Health (5rc2ns070276-02, NS070276)
- U.S. Public Health Service (C024406)
- National Institute of Mental Health (R25MH077823)
- National Institute on Drug Abuse (R01DA026947)
- National Institute of Neurological Disorders and Stroke (RC2-NS070276, NS061856, R01NS061856, NS071122, NS070276, R01NS071122)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkin, Parkinson's disease, dopaminergic neurons, midbrain, dopamine uptake, dopamine release, monoamine oxidase, oxidative stress, induced pluripotent stem cells, parkin mutations, ubiquitin ligase, disease-modifying therapy
- MeSH terms
- Animals, Binding Sites, Brain, Dopamine, Fibroblasts, Gene Expression Regulation, Humans, Mitochondria, Models, Biological, Monoamine Oxidase, Mutation, Neurons, Oxygen, Parkinson Disease, Phenotype, Skin, Time Factors, Oxidative Stress, Ubiquitin-Protein Ligases, Mice, Induced Pluripotent Stem Cells, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.